Catalyst Wire Dossier Catalyst Wire Dossier

GSK2186877A influenza vaccine

GSK2186877A · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK2186877A influenza vaccine, covering 2012-04-05 to 2012-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older [Phase 3]

See pricing